Lobbying client · LD-2 disclosures
Adaptive Phage Therapeutics
Maryland
27 filings from 2 registrants · 2020–2025 · latest filed Jul 20, 2025
Reported on its behalf
$100K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$100K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medical/Disease Research/Clinical Labs
MED
7 filings
$100K on those filings
Budget/Appropriations
BUD
4 filings
$20K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Who did the lobbying
Every lobbyist named on this client's filings.
- Darin L Gardner The Conafay Group, LLCCovered position: Legislative Correspondent Senator Tim Hutchinson; Research Associate Senate HELP Committee; Chief of Staff Congresswoman Kay Granger5 filingsthrough 2022
- Aishat Magbade The Conafay Group, LLC4 filingsthrough 2022
- John Milne Milne, Wiener & Shofe Global Strategies (Fka M & W Government Affairs, LLC)4 filingsthrough 2020
- Jeffrey S Wiener Milne, Wiener & Shofe Global Strategies (Fka M & W Government Affairs, LLC)Covered position: Legislative Assistant to Senator Mary Landrieu (D-LA)4 filingsthrough 2020
The filings
The 20 most recent of 27 filings. Every figure above is built from these records.
| Period | Registrant | Type | Reported | Record |
|---|---|---|---|---|
| 2nd Quarter (Apr 1 - June 30) 2025 | Milne, Wiener & Shofe Global Strategies (Fka M & W Government Affairs, LLC) | 2nd Quarter - Termination (No Activity) | — | Filing · LD-2 ↗ |
| 1st Quarter (Jan 1 - Mar 31) 2025 | Milne, Wiener & Shofe Global Strategies (Fka M & W Government Affairs, LLC) |
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: adaptive-phage-therapeutics.